BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 34238312)

  • 1. APOE genotype dependent molecular abnormalities in the cerebrovasculature of Alzheimer's disease and age-matched non-demented brains.
    Ojo JO; Reed JM; Crynen G; Vallabhaneni P; Evans J; Shackleton B; Eisenbaum M; Ringland C; Edsell A; Mullan M; Crawford F; Bachmeier C
    Mol Brain; 2021 Jul; 14(1):110. PubMed ID: 34238312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Pathobiology of the Cerebrovasculature in Aging and in Alzheimers Disease Cases With Cerebral Amyloid Angiopathy.
    Ojo JO; Reed JM; Crynen G; Vallabhaneni P; Evans J; Shackleton B; Eisenbaum M; Ringland C; Edsell A; Mullan M; Crawford F; Bachmeier C
    Front Aging Neurosci; 2021; 13():658605. PubMed ID: 34079449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma ApoE4 Levels Are Lower than ApoE2 and ApoE3 Levels, and Not Associated with Plasma Aβ40/42 Ratio as a Biomarker of Amyloid-β Amyloidosis in Alzheimer's Disease.
    Nakamura T; Kawarabayashi T; Ueda T; Shimomura S; Hoshino M; Itoh K; Ihara K; Nakaji S; Takatama M; Ikeda Y; Shoji M
    J Alzheimers Dis; 2023; 93(1):333-348. PubMed ID: 36970894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential Signaling Mediated by ApoE2, ApoE3, and ApoE4 in Human Neurons Parallels Alzheimer's Disease Risk.
    Huang YA; Zhou B; Nabet AM; Wernig M; Südhof TC
    J Neurosci; 2019 Sep; 39(37):7408-7427. PubMed ID: 31331998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total Cholesterol and APOE-Related Risk for Alzheimer's Disease in the Alzheimer's Disease Neuroimaging Initiative.
    Dunk MM; Driscoll I;
    J Alzheimers Dis; 2022; 85(4):1519-1528. PubMed ID: 34958023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monomeric C-reactive protein via endothelial CD31 for neurovascular inflammation in an ApoE genotype-dependent pattern: A risk factor for Alzheimer's disease?
    Zhang Z; Na H; Gan Q; Tao Q; Alekseyev Y; Hu J; Yan Z; Yang JB; Tian H; Zhu S; Li Q; Rajab IM; Blusztajn JK; Wolozin B; Emili A; Zhang X; Stein T; Potempa LA; Qiu WQ
    Aging Cell; 2021 Nov; 20(11):e13501. PubMed ID: 34687487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Thai Nationals, the ApoE4 Allele Affects Multiple Domains of Neuropsychological, Biobehavioral, and Social Functioning Thereby Contributing to Alzheimer's Disorder, while the ApoE3 Allele Protects Against Neuropsychiatric Symptoms and Psychosocial Deficits.
    Tangwongchai S; Supasitthumrong T; Hemrunroj S; Tunvirachaisakul C; Chuchuen P; Houngngam N; Snabboon T; Tawankanjanachot I; Likitchareon Y; Phanthumchindad K; Maes M
    Mol Neurobiol; 2018 Aug; 55(8):6449-6462. PubMed ID: 29307083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuron-specific apolipoprotein e4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice.
    Brecht WJ; Harris FM; Chang S; Tesseur I; Yu GQ; Xu Q; Dee Fish J; Wyss-Coray T; Buttini M; Mucke L; Mahley RW; Huang Y
    J Neurosci; 2004 Mar; 24(10):2527-34. PubMed ID: 15014128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular Dysfunction Is Central to Alzheimer's Disease Pathogenesis in APOE e4 Carriers.
    McCorkindale AN; Mundell HD; Guennewig B; Sutherland GT
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.
    Martínez-Morillo E; Hansson O; Atagi Y; Bu G; Minthon L; Diamandis EP; Nielsen HM
    Acta Neuropathol; 2014 May; 127(5):633-43. PubMed ID: 24633805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular signatures in post-mortem brain tissue of younger individuals at high risk for Alzheimer's disease as based on APOE genotype.
    Conejero-Goldberg C; Hyde TM; Chen S; Dreses-Werringloer U; Herman MM; Kleinman JE; Davies P; Goldberg TE
    Mol Psychiatry; 2011 Aug; 16(8):836-47. PubMed ID: 20479757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human ApoE Isoforms Differentially Modulate Glucose and Amyloid Metabolic Pathways in Female Brain: Evidence of the Mechanism of Neuroprotection by ApoE2 and Implications for Alzheimer's Disease Prevention and Early Intervention.
    Keeney JT; Ibrahimi S; Zhao L
    J Alzheimers Dis; 2015; 48(2):411-24. PubMed ID: 26402005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein E and oxidative stress in brain with relevance to Alzheimer's disease.
    Butterfield DA; Mattson MP
    Neurobiol Dis; 2020 May; 138():104795. PubMed ID: 32036033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein E genotypes and plasma levels in mild cognitive impairment conversion to Alzheimer's disease: A follow-up study.
    Scarabino D; Broggio E; Gambina G; Maida C; Gaudio MR; Corbo RM
    Am J Med Genet B Neuropsychiatr Genet; 2016 Dec; 171(8):1131-1138. PubMed ID: 27604972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Apolipoprotein E genotypes in patients investigated for dementia].
    Johannsen P; Jakobsen JK; Jørgensen AL
    Ugeskr Laeger; 1997 Sep; 159(38):5658-61. PubMed ID: 9340872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. APOE gene-dependent BOLD responses to a breath-hold across the adult lifespan.
    Rasmussen PM; Aamand R; Weitzberg E; Christiansen M; Østergaard L; Lund TE
    Neuroimage Clin; 2019; 24():101955. PubMed ID: 31408838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LRP1 in vascular mural cells modulates cerebrovascular integrity and function in the presence of APOE4.
    Oue H; Yamazaki Y; Qiao W; Yuanxin C; Ren Y; Kurti A; Shue F; Parsons TM; Perkerson RB; Kawatani K; Wang N; Starling SC; Roy B; Mosneag IE; Aikawa T; Holm ML; Liu CC; Inoue Y; Sullivan PM; Asmann YW; Kim BY; Bu G; Kanekiyo T
    JCI Insight; 2023 Apr; 8(7):. PubMed ID: 37036005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain metabolic decreases related to the dose of the ApoE e4 allele in Alzheimer's disease.
    Mosconi L; Nacmias B; Sorbi S; De Cristofaro MT; Fayazz M; Tedde A; Bracco L; Herholz K; Pupi A
    J Neurol Neurosurg Psychiatry; 2004 Mar; 75(3):370-6. PubMed ID: 14966149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein E isoform-specific regulation of dendritic spine morphology in apolipoprotein E transgenic mice and Alzheimer's disease patients.
    Ji Y; Gong Y; Gan W; Beach T; Holtzman DM; Wisniewski T
    Neuroscience; 2003; 122(2):305-15. PubMed ID: 14614898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid beta peptides but not on plaque formation.
    Buttini M; Yu GQ; Shockley K; Huang Y; Jones B; Masliah E; Mallory M; Yeo T; Longo FM; Mucke L
    J Neurosci; 2002 Dec; 22(24):10539-48. PubMed ID: 12486146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.